Levaquin Settlement Website Offers New Information For Consumers

April 12, 2017 – – A popular website that focuses on Levaquin settlement and trials has released new information regarding these cases. Levaquin-lawsuit.org is a consumer information website that keeps the public informed of new happenings regarding lawsuits focused on Levaquin, an antibiotic manufactured and distributed by pharmaceutical company Johnson & Johnson.

“Our goal is to ensure that the public is aware of these lawsuits, what they entail, and the outcome regarding settlements to those injured as a result of taking this drug,” says a spokesperson for the site. “We regularly update our information, keeping track of trials and out of court settlements as much as possible.”

The site also lists a timeline for the trials as well as for studies that have been done that show the dangers of taking these medications. The trials mainly focus on peripheral neuropathy, a nerve condition that causes pain and weakness in the hands and feet.

“The lawsuits target Janssen Pharmaceutical, which is a subsidiary of Johnson & Johnson,” says the site representative. “These are not the only cases being tried that include the pharmaceutical giant as they are also under scrutiny for additional drugs as well as various products that are all being targeted for product liability.”

Levaquin belongs to a class of antibiotics known as fluoroquinolones. The drugs are among the most frequently administered in the United States, being prescribed to millions of consumers to treat STDs as well as bacterial infections and pneumonia. Before studies were done on the drugs, they were frequently prescribed to treat minor infections such as bronchitis, urinary tract infections and sinusitis. Due to lawsuits and recent studies, the FDA has strongly warned against using these medications to treat such uncomplicated infections due to the fact that their risks far outweigh their benefits. Levaquin-lawsuit.org offers this information as well as resources for those who have been injured by the drugs and information on filing claims against the pharmaceutical companies that distribute them.

Those interested in learning more about the lawsuits or the development and release of Levaquin and a timeline of the drug’s studies can visit the consumer information website online.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60016939